PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DS23F00368509606738!ihealth covid-19 antigen RAPI — Ihealth Labs Inc

PoP ended May 11, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support
Awarding office
Department of Defense (DOD)
Agency
Ihealth Labs Inc
Recipient
May 11, 2023
PoP end
$190.8M
Obligated
325413
NAICS
6640
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract numberSPE2DS23F0036
Also listed asSPE2DS-23-F-0036
Also listed asSPE2DE23D0012-SPE2DS23F0036
AgencyDepartment of Defense (DOD)
Awarding officeDla Troop Support
IncumbentIhealth Labs Inc
UEIRSKJC51FNLR3
NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6640
Parent IDIQ / IDVSPE2DE23D0012
Place of performanceSAN JOSE, CA
PoP end (current)May 11, 2023
Obligated$190.8M

8509606738!IHEALTH COVID-19 ANTIGEN RAPI is a federal award for Department of Defense (DOD) held by Ihealth Labs Inc. Estimated value $190.8M ($190.8M obligated). Current period of performance ends May 11, 2023. Place of performance: SAN JOSE, CA.

Recompete timing

Public
● Past PoP end (1239 days ago)

Current PoP ended May 11, 2023 (1239 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on SPE2DS23F0036? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Explore more pipelines →

Frequently asked questions

What is contract SPE2DS23F0036?

SPE2DS23F0036 (8509606738!ihealth covid-19 antigen RAPI) is a Dla Troop Support award with an estimated value of $190.8M, currently held by Ihealth Labs Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is SPE2DS-23-F-0036?

SPE2DS-23-F-0036 is the dashed form of PIID SPE2DS23F0036 (8509606738!ihealth covid-19 antigen RAPI), held by Ihealth Labs Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded SPE2DS23F0036?

Dla Troop Support awarded SPE2DS23F0036 to Ihealth Labs Inc.

Who is the incumbent on SPE2DS23F0036?

Ihealth Labs Inc is the incumbent. The current period of performance ends May 11, 2023.

When does Ihealth Labs Inc’s SPE2DS23F0036 come up for recompete?

SCOUT tracks a period-of-performance end of May 11, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on SPE2DS23F0036? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2DS23F0036